The Precision Interventions for Severe and/or Exacerbation-Prone Asthma Network (PrecISE) is a clinical study sponsored by the National Heart, Lung, and Blood Institute (NHLBI). PrecISE's physician scientists are dedicated to researching better treatments for people living with severe asthma.
PrecISE is a clinical study that uses precision medicine for severe asthma. Precision medicine is an approach to the prevention and treatment of disease that uses information about an individual's or group's specific disease process, symptoms, and treatment responses, to identify the medicines and therapies that are most likely to be effective for them.
Researchers from over 30 locations across the US are involved in PrecISE.
See the latest updates about COVID-19 and PrecISE here.
Study Site Locations
Click on a state below for a list of study sites by city. You can also view a list of all states, and the cities where study locations are located, here.